Main Industry
Health Care
Main Product/Service
Research and development of botanical drugs for the treatment of benign prostatic hyperplasia (enlarged prostate), prostate cancer, and prostate inflammation.
The content above was translated by Ai
Founded Year
2010
Unified Business No.
24526130
Status
Active
Number of Employees
0
Total Paid-in
Capital
15,000,000 (NT$)
Location of Company
Taiwan
, Kaohsiung City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Our company enjoys the collaboration of outstanding talents across various professional fields and possesses innovative research and development achievements. Our production and manufacturing process capabilities are highly mature. We have successively researched and developed nutritional health supplements and health-and-medical-related products in application fields for acute and chronic diseases, such as Hepatitis B, Hepatitis C, acute hepatitis, fatty liver, liver cirrhosis, prostate diseases, and osteoporosis. In addition to the three prostate diseases being recognized by multiple countries, we have also obtained approval from the Taiwan Intellectual Property Office for the world's first priority examination for seven liver diseases and two arthritis conditions, and have applied for patents in multiple countries.
The content above was translated by Ai
